Nascent Biotech (OTCMKTS:NBIO) Shares Pass Below 50-Day Moving Average of $0.09

Retrieved on: 2024-07-11 11:50:01

Tags for this article:

Stock market

Pritumumab

Stock

Volume

Click the tags to see associated articles and topics

Nascent Biotech (OTCMKTS:NBIO) Shares Pass Below 50-Day Moving Average of $0.09. View article details on hiswai:

Summary

The article discusses Nascent Biotech, Inc. and its stock performance, specifically noting the decline of its share price below the 50-day moving average and the trading volume. It highlights Pritumumab, a biotech drug for treating various cancers.

Article found on: www.defenseworld.net

View Original Article